A phase 2/3, observer-blind, randomized, controlled study to determine the safety & immunogenicity of Covishield (Covid-19 vaccine) in healthy Indian adults
Implementing Organization
The INCLEN Trust International
Principal Investigator
Ms. C. Padmapriyadarsini Director The INCLEN Trust International Delhi